Open AccessMedication‐induced obstructive uropathy and hyperprolactinemia in a pediatric patient
Author(s) -
NkansahAmankra Kwabena,
Sudhanthar Sathyanarayan
Publication year - 2019
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.2396
Subject(s) - medicine , obstructive uropathy , pediatrics , intensive care medicine , urinary system
Hyperprolactinemia can result from a pituitary tumor or decreased dopamine levels due to compression of the pituitary stalk. Hypothyroidism, renal failure, and drug interaction need to be ruled out as a part of diagnostic evaluation. The prolactin level often indicates the etiology, but drug interaction needs to be ruled out mainly in a patient who is on multiple medications.